Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer
Clinical trial NCT02390739 · WITHDRAWN
Trial details
- NCT number
- NCT02390739
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-02
- Primary completion
- 2017-03-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.